GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Fluicell AB (OSTO:FLUI) » Definitions » Gross Margin %

Fluicell AB (OSTO:FLUI) Gross Margin % : 36.56% (As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Fluicell AB Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Fluicell AB's Gross Profit for the three months ended in Mar. 2024 was kr0.12 Mil. Fluicell AB's Revenue for the three months ended in Mar. 2024 was kr0.32 Mil. Therefore, Fluicell AB's Gross Margin % for the quarter that ended in Mar. 2024 was 36.56%.

Warning Sign:

Fluicell AB gross margin has been in long-term decline. The average rate of decline per year is -4.3%.


The historical rank and industry rank for Fluicell AB's Gross Margin % or its related term are showing as below:

OSTO:FLUI' s Gross Margin % Range Over the Past 10 Years
Min: 20.93   Med: 72.52   Max: 82.19
Current: 20.93


During the past 9 years, the highest Gross Margin % of Fluicell AB was 82.19%. The lowest was 20.93%. And the median was 72.52%.

OSTO:FLUI's Gross Margin % is ranked worse than
83.6% of 750 companies
in the Biotechnology industry
Industry Median: 60.91 vs OSTO:FLUI: 20.93

Fluicell AB had a gross margin of 36.56% for the quarter that ended in Mar. 2024 => Competition eroding margins

The 5-Year average Growth Rate of Gross Margin for Fluicell AB was -4.30% per year.


Fluicell AB Gross Margin % Historical Data

The historical data trend for Fluicell AB's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fluicell AB Gross Margin % Chart

Fluicell AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Margin %
Get a 7-Day Free Trial Premium Member Only 82.19 78.68 72.52 79.61 52.07

Fluicell AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 81.62 72.42 -101.50 -108.53 36.56

Competitive Comparison of Fluicell AB's Gross Margin %

For the Biotechnology subindustry, Fluicell AB's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fluicell AB's Gross Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Fluicell AB's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Fluicell AB's Gross Margin % falls into.



Fluicell AB Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Fluicell AB's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )=Gross Profit (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=1.7 / 3.338
=(Revenue - Cost of Goods Sold) / Revenue
=(3.338 - 1.6) / 3.338
=52.07 %

Fluicell AB's Gross Margin for the quarter that ended in Mar. 2024 is calculated as


Gross Margin % (Q: Mar. 2024 )=Gross Profit (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=0.1 / 0.32
=(Revenue - Cost of Goods Sold) / Revenue
=(0.32 - 0.203) / 0.32
=36.56 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Fluicell AB  (OSTO:FLUI) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Fluicell AB had a gross margin of 36.56% for the quarter that ended in Mar. 2024 => Competition eroding margins


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Fluicell AB Gross Margin % Related Terms

Thank you for viewing the detailed overview of Fluicell AB's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Fluicell AB (OSTO:FLUI) Business Description

Traded in Other Exchanges
Address
Biotech-Huset, van 7, Arvid Wallgrens Backe 20, Gothenburg, SWE, SE-413 46
Fluicell AB is a provider of high resolution SINGLE-CELL DISCOVERY PLATFORMS for biomedicine, drug development, and bioprinting. The company's products include Biopen, Dynaflow.

Fluicell AB (OSTO:FLUI) Headlines

No Headlines